Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Othman

Showing results (81-90 of 474) with videos related to

Pageof 48
Sort By:
Clinical Pharmacokinetics|January 16, 2018
Pharmacokinetics of the B-Cell Lymphoma 2 (Bcl-2) Inhibitor Venetoclax in Female Subjects with Systemic Lupus ErythematosusMukul Minocha, Jiewei Zeng, Jeroen K Medema, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
N-(3-Chloro-propion-yl)-N'-phenyl-thio-ureaEliyanti A Othman, Siti K C Soh, Bohari M Yamin
Clinical Pharmacology in Drug Development|August 30, 2018
Pharmacokinetics, Safety, and Tolerability of the Dual Inhibitor of Tumor Necrosis Factor-α and Interleukin 17A, ABBV-257, in Healthy Volunteers and Patients With Rheumatoid ArthritisAhmed A Othman, Amit Khatri, Ralf Loebbert, et al.
Clinical Pharmacokinetics|August 21, 2018
Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn's Disease: Analyses of Phase I and II TrialsAhmed A Suleiman, Amit Khatri, Mukul Minocha, et al.
Atherosclerosis|November 26, 2013
Non-cholesterol sterols and cholesterol metabolism in sitosterolemiaRgia A Othman, Semone B Myrie, Peter J H Jones
Journal of Clinical Pharmacology|September 22, 2020
Therapeutic Protein Drug Interaction Potential in Subjects With Psoriasis: An Assessment Based on Population Pharmacokinetic Analyses of Sensitive Cytochrome P450 Probe SubstratesAbhishek G Sathe, Ahmed A Othman, Mohamed-Eslam F Mohamed
Advances in Skin & Wound Care|May 7, 2021
The Effectiveness of Vacuum-Assisted Closure Device in Managing Intramuscular TuberculosisSharifah A Othman, Tarek M ElSharkawy, Doaa Alfaifi, et al.
Journal of Clinical Pharmacology|May 14, 2011
Pharmacokinetics of the TRPV1 antagonist ABT-102 in healthy human volunteers: population analysis of data from 3 phase 1 trialsAhmed A Othman, Wolfram Nothaft, Walid M Awni, et al.
Journal of Animal Physiology and Animal Nutrition|May 11, 2006
Recovery of age-dependent immunological deterioration in old mice by thyroxine treatmentK A El-Shaikh, M S Gabry, G A Othman
Scientific Reports|May 17, 2026
Wave propagation and thermal behavior in nonlocal thermoelastic porous media under moving heat sources with three-phase-lag and Green-Naghdi modelsMohamed I A Othman, Samia M Said, Esraa M Gamal
Pageof 48

Showing results (81-90 of 474) with videos related to

Sort By:
Pageof 48
Clinical Pharmacokinetics|January 16, 2018
Pharmacokinetics of the B-Cell Lymphoma 2 (Bcl-2) Inhibitor Venetoclax in Female Subjects with Systemic Lupus ErythematosusMukul Minocha, Jiewei Zeng, Jeroen K Medema, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
N-(3-Chloro-propion-yl)-N'-phenyl-thio-ureaEliyanti A Othman, Siti K C Soh, Bohari M Yamin
Clinical Pharmacology in Drug Development|August 30, 2018
Pharmacokinetics, Safety, and Tolerability of the Dual Inhibitor of Tumor Necrosis Factor-α and Interleukin 17A, ABBV-257, in Healthy Volunteers and Patients With Rheumatoid ArthritisAhmed A Othman, Amit Khatri, Ralf Loebbert, et al.
Clinical Pharmacokinetics|August 21, 2018
Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn's Disease: Analyses of Phase I and II TrialsAhmed A Suleiman, Amit Khatri, Mukul Minocha, et al.
Atherosclerosis|November 26, 2013
Non-cholesterol sterols and cholesterol metabolism in sitosterolemiaRgia A Othman, Semone B Myrie, Peter J H Jones
Journal of Clinical Pharmacology|September 22, 2020
Therapeutic Protein Drug Interaction Potential in Subjects With Psoriasis: An Assessment Based on Population Pharmacokinetic Analyses of Sensitive Cytochrome P450 Probe SubstratesAbhishek G Sathe, Ahmed A Othman, Mohamed-Eslam F Mohamed
Advances in Skin & Wound Care|May 7, 2021
The Effectiveness of Vacuum-Assisted Closure Device in Managing Intramuscular TuberculosisSharifah A Othman, Tarek M ElSharkawy, Doaa Alfaifi, et al.
Journal of Clinical Pharmacology|May 14, 2011
Pharmacokinetics of the TRPV1 antagonist ABT-102 in healthy human volunteers: population analysis of data from 3 phase 1 trialsAhmed A Othman, Wolfram Nothaft, Walid M Awni, et al.
Journal of Animal Physiology and Animal Nutrition|May 11, 2006
Recovery of age-dependent immunological deterioration in old mice by thyroxine treatmentK A El-Shaikh, M S Gabry, G A Othman
Scientific Reports|May 17, 2026
Wave propagation and thermal behavior in nonlocal thermoelastic porous media under moving heat sources with three-phase-lag and Green-Naghdi modelsMohamed I A Othman, Samia M Said, Esraa M Gamal
Pageof 48